Yuhan Corporation (KRX:000105)
106,750
-1,050 (-0.97%)
Last updated: Sep 9, 2025, 11:19 AM KST
Yuhan Market Cap
Yuhan has a market cap or net worth of 9.10 trillion as of September 8, 2025. Its market cap has increased by 37.58% in one year.
Market Cap
9.10T
Enterprise Value
9.16T
Revenue
2.17T
Ranking
n/a
PE Ratio
114.98
Stock Price
106,750.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 9.10T, an increase of 3,828.69%. That is a compound annual growth rate of 16.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 9,104.15B | 1.79% |
Dec 30, 2024 | 8,943.65B | 73.59% |
Dec 28, 2023 | 5,152.13B | 25.86% |
Dec 29, 2022 | 4,093.46B | -3.94% |
Dec 30, 2021 | 4,261.56B | -9.20% |
Dec 30, 2020 | 4,693.09B | 58.97% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.31T |
Celltrion | 37.23T |
ALTEOGEN | 25.41T |
Yuhan | 8,902.27B |
SK Biopharmaceuticals | 8,551.81B |
Peptron | 7,070.75B |
PharmaResearch | 6,545.48B |
ABL Bio | 5,621.23B |